Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial DNA replication machinery is a **multiprotein complex, known as the replisome, responsible for copying the bacterial genome prior to cell division**[1][2][5][6]. The machinery orchestrates the processes of DNA strand separation, RNA primer synthesis, deoxyribonucleotide addition, and joining of DNA fragments. Core components are highly conserved, particularly in model organisms like *Escherichia coli*, and include enzymes such as DNA polymerase III (the main replicative polymerase), DnaB helicase (unwinds DNA), DnaG primase (synthesizes RNA primers), DNA ligase (seals DNA fragments), single-strand binding proteins (protect ssDNA), and topoisomerase II/DNA gyrase (relaxes supercoiled DNA)[1][2][3][4][6]. The system initiates at the origin of replication (oriC) and progresses bidirectionally, with key regulatory proteins (e.g., DnaA) controlling timing and specificity of initiation[2][4]. The machinery is **essential for bacterial survival**, making it a validated and intensively investigated **therapeutic target for antibacterial drugs**, particularly those that inhibit DNA gyrase or DNA polymerase III[2][3][6]. While mainly a target in the context of infection, resistance mutations in machinery components can drive antibiotic resistance, complicating clinical management[3][4]. Disruption of these proteins or their coordination is lethal to bacteria, underlying their significance in antimicrobial strategy[6].
Inhibition of DNA gyrase/topoisomerase II (blocks DNA supercoiling/relaxation) - Inhibition of DNA polymerase III (blocks DNA chain elongation) - Disruption of primase activity (blocks RNA primer synthesis) - Interference with helicase function (blocks DNA strand separation) - Stabilization or disruption of DNA-protein complexes causing lethal DNA breaks
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial DNA replication machinery.